Agenus Inc. (NASDAQCM:AGEN) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $4.09, up from yesterday’s close by 0.49%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.
Does this stock stack up well when compared to its peers in the space? Let’s take a look. Agenus Inc. (AGEN) currently trades with a market capitalization of $356.36M. That value represents a market adjusting for revenues that have been falling by -35.10% on a quarterly year/year basis as of the company’s last quarterly report.
The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For AGEN, the company currently has $95.40M of cash on the books, which is offset by $126.41M current liabilities. You can get a sense of how sustainable that is by a levered free cash flow of $-69.96M over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of -0.33 on a per share basis this quarter. Perhaps, that suggests something about why 50.00% of the outstanding share supply is held by institutional investors.
We’ve taken a serious look at this stock from a fundamental perspective, but the tale of the tape may offer more hints about what lies under the surface. Looking at the stock’s movement on the chart, Agenus Inc. recorded a 52-week high of 7.49. It is now trading 3.42 off that level. The stock is trading 4.26 its 50-day moving average by 0.19. The stock carved out a 52-week low down at 2.61.
In recent action, Agenus Inc. (AGEN) has made a move of -3.08% over the past month, which has come on Strong relative transaction volume. Over the trailing year, the stock is outperforming the S&P 500 by 14.07, and it’s gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 74.30M with 12.11% sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of AGEN.